Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023
SEATTLE, April 06, 2023 -- Adaptive Biotechnologies Corporation , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products... | April 6, 2023
Karina Calzadilla Adaptive Biotechnologies Corporation Nasdaq Biotechnologies Corporation Minimal Residual Disease Vice President Adaptive Biotechnologies Corporation Stock Exchange
Source: marketscreener.com